Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyFri, 26 Jul 2024 22:08:23 +0200Fri, 26 Jul 2024 12:00:00 +0200Human medicines European public assessment report (EPAR): Kayfanda, odevixibat, Status: Opinionhttps://www.ema.europa.eu/en/medicines/human/EPAR/kayfandaHuman medicines European public assessment report (EPAR): Kayfanda, odevixibat, Status: Opinionhttps://www.ema.europa.eu/en/medicines/human/EPAR/kayfandaFri, 26 Jul 2024 12:00:00 +0200Human medicine